Desktop Site |
21 Nov 24 | 16:00 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 77,155.79 -422.59 -0.54 %
Corporate Announcement
  • Security Code532296
    CompanyGLENMARK PHARMACEUTICALS LTD.
    Exchange Received Time14/11/2024 18:37:10
    Exchange Disseminated Time14/11/2024 18:37:11
    Time Taken00:00:01
     
     
     Board Meeting Outcome for Unaudited Financial Results (Standalone And Consolidated) For The Second Quarter And Half Year Ended 30Th September, 2024 | 11/14/2024 6:37:11 PM 
     Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform that the Board at its meeting held today has approved the unaudited financial results for the Second Quarter and Half Year ended 30th September, 2024. The said Board Meeting commenced at 02:00 p.m. and ended at 6.20 p.m. 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(18) 21 Nov 24|23:39 (IST)